• NORD Honors Industry, Patient Advocates at Rare Impact Awards Gala
  • Cosentyx Slightly Better Than NSAIDs in Reducing Disease Progression, Data Analysis Shows
  • Bimekizumab Can Improve Outcomes of AS Patients, Phase 2b Trial Finds
  • Eurordis Unveils Integrated-care Initiative for Rare Disease Patients
  • When Pain Becomes Your Constant Friend
  • ‘Rare Barometer’ Program Helps Eurordis Shape EU Rare Disease Policy
  • ‘Multimorbidity’ More Likely in Axial Spondyloarthropathy, Linked to Worse Outcomes, Irish Study Finds
  • Study Finds No Benefit in Screening AS Patients for Heart Disease Absent Clinical Symptoms
  • Mind Over Matter: Can Optimism Change Our Disease?
  • Spinal Mobility Problems Common, and Worsen Over Time, Swedish Study Shows
  • Physical Function in AS Not Affected by Other Comorbidities, Study Suggests
  • Different Types of Axial Spondyloarthritis Share the Same Other Diseases, Study Says